Tone Jensen-Skeie

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Pelvic exenteration for cervical cancer - Oncologic outcome and long-term health-related quality of life, a mixed methods study.

Pelvic exenteration for cervical cancer - Oncologic outcome and long-term health-related quality of life, a mixed methods study.

Journal: Gynecologic oncology
Published: March 30, 2026

Deep Learning Can Accurately Predict the Prognosis of Gynecologic Smooth Muscle Tumors of Uncertain Malignant Potential: A Multicenter Pilot Study.

Deep Learning Can Accurately Predict the Prognosis of Gynecologic Smooth Muscle Tumors of Uncertain Malignant Potential: A Multicenter Pilot Study.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: January 29, 2025

Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma.

Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: June 07, 2024

Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.

Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.

Journal: Virchows Archiv : an international journal of pathology
Published: July 31, 2023

Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis.

Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 05, 2023

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas.

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas.

Journal: The American journal of surgical pathology
Published: June 17, 2017

Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.

Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.

Journal: Virchows Archiv : an international journal of pathology
Published: March 08, 2017

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Journal: British journal of cancer
Published: July 01, 2016

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 30, 2012

Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.

Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.

Journal: Gynecologic oncology
Published: September 26, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026